Xpert MTB/XDR for rapid detection of drug-resistant tuberculosis beyond rifampicin

Lancet Infect Dis. 2022 Feb;22(2):156-157. doi: 10.1016/S1473-3099(21)00481-3. Epub 2021 Oct 7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibiotics, Antitubercular* / pharmacology
  • Antibiotics, Antitubercular* / therapeutic use
  • Humans
  • Rifampin / pharmacology
  • Rifampin / therapeutic use
  • Tuberculosis, Multidrug-Resistant* / diagnosis
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antibiotics, Antitubercular
  • Rifampin